FDA declines to approve Astellas' gastric cancer drug

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 09, 2024 at 09:52: AM
via Japan's Astellas Pharma (4503.T) said on Monday the U.S. Food and Drug Administration (FDA) has declined to approve its experimental drug to treat a type of gastric cancer, citing issues related to a third-party manufacturer.

article source
 

<



Similar threads

cafead
FDA declines to approve Regeneron&#039;s blood cancer therapy
Replies
0
Views
30
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA declines to approve Merck-Daiichi&#039;s &#039;guided missile&#039; cancer drug
Replies
0
Views
24
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA declines to approve Shin Nippon Biomedical&#039;s migraine drug
Replies
0
Views
57
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Immunitybio slumps as FDA declines to approve bladder cancer treatment
Replies
0
Views
107
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA declines to approve Eli Lilly&#039;s bowel disease drug
Replies
0
Views
270
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote